According to the National Institutes of Health, between 600,000 and 900,000 Americans have ulcerative colitis, a chronic ...

Mirikizumab treatment is safe and efficacious for ulcerative colitis up to 152 weeks in those with and without previous biologic therapy failure. Mirikizumab treatment for 152 weeks is associated with ...

An experimental monoclonal antibody treatment appears to ease the digestive disorder ulcerative colitis in patients who've failed other medications, a new trial shows. The treatment, tulisokibart, ...

Ulcerative Colitis Market grows at 5.4% CAGR (2025–2033), reaching US$ 12.79 Billion on rising biologic adoption, biosimilars, and personalized IBD therapies. North America leads the ulcerative ...

In certain patients, JAK inhibitor rescue medications seem to be more effective, researche ...

Mirikizumab is a drug currently approved by the Food and Drug Administration (FDA) for the treatment of ulcerative colitis. Pharmaceutical company Eli Lilly recently released findings of two studies ...

A patient at the University of Chicago became the first person to receive a recently FDA-approved treatment for moderate to severe ulcerative colitis, according to a Sept. 17 news release by the ...

Dear K.G.: Microscopic colitis is a chronic inflammatory disease of the colon. It comes in two pathologic forms — collagenous ...